In a time of rapidly transforming communication technologies, developers and researchers are creating new ways to track and combat disease. A new book presents an integrated look at the methods that are shaping the use of communication technology in health care.
Source: New Book Looks at Communication Technology in Global Health | RTI-HS
SEEKING JOB OPPORTUNITY – Healthcare | Pharmaceuticals | SpecialtyPharmacy | Biotech – Managed Care | Sales/Marketing | Business Development
Check out my LinkedIn profile
email – firstname.lastname@example.org
Iowa’s controversial move to privatize its Medicaid program has cost participating insurers an estimated $450 million in losses.
Source: Iowa requests CMS pay up to $225 million for Medicaid managed-care losses – Modern Healthcare
Every year, physician groups take doctors’ temperature on the issue of pay, and every year, they are feverish.
Source: How Doctors Are Paid Now, And Why It Has to Change | Managed Care Magazine Online
While coupons help individual consumers, they are also having a major impact on the insurance industry and anyone responsible for paying health care bills. Insurers and pharmacy benefit managers complain that they foil formularies and other pricing strategies designed to steer consumers to less-expensive drugs.
Source: Health Insurers Often Foot Bill When Drug Coupons Are Used | Managed Care Magazine Online
When Harvard Pilgrim Health Care recently unveiled value-based contracts for two expensive medications, etanercept (Enbrel) and teriparatide (Forteo), the news caused a stir
Source: Value-Based Contracting Between Insurers and Drug Companies Faces Tough Hurdles | Managed Care Magazine Online
Although team-based care improved cardiovascular disease risk factors, it had a negative financial impact on a primary care practice.
Source: The Financial Impact of Team-Based Care on Primary Care
The Academy of Managed Care Pharmacy Annual Meeting kicked off on March 28, 2017, in Denver, Colorado, with a look at the specialty pharmaceutical pipeline with Aimee Tharaldson, PharmD, senior clinical consultant for emerging therapeutics at Express Scripts.
Source: Analyzing the Near-Term Pipeline for Specialty Drugs
There is a trend of making value-based deals to pay for treatments in order to ensure the drug works as advertised while also protecting payers from financial risk, explained Richard J. Willke, PhD, chief science officer of ISPOR.
Source: Dr Richard Willke on Using Real-World Data to Inform Value-Based Contracts